Cargando…
Musings on malaria morbidity and mortality after the new Mosquirix(®) vaccine
Autor principal: | Sackey, Adziri H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ghana Medical Association
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6697765/ https://www.ncbi.nlm.nih.gov/pubmed/31481817 http://dx.doi.org/10.4314/gmj.v53i2.16 |
Ejemplares similares
-
Re: Musings on malaria morbidity and mortality after the new Mosquirix(®) vaccine
por: Asante, Kwaku Poku, et al.
Publicado: (2019) -
RTS,S/AS01 malaria vaccine (Mosquirix(®)): a profile of its use
por: Syed, Yahiya Y.
Publicado: (2022) -
Mosquirix™ RTS, S/AS01 Vaccine Development, Immunogenicity, and Efficacy
por: Nadeem, Aroosa Younis, et al.
Publicado: (2022) -
In-silico analysis of potent Mosquirix vaccine adjuvant leads
por: Onyango, Okello Harrison, et al.
Publicado: (2023) -
Admissions and mortality over a 5-year period in a limited-resource neonatal unit in Ghana
por: Sackey, Adziri H, et al.
Publicado: (2019)